BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 30200951)

  • 1. A novel synthetic trivalent single chain variable fragment (tri-scFv) construction platform based on the SpyTag/SpyCatcher protein ligase system.
    Alam MK; Brabant M; Viswas RS; Barreto K; Fonge H; Ronald Geyer C
    BMC Biotechnol; 2018 Sep; 18(1):55. PubMed ID: 30200951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-Specific Fluorescent Labeling of Antibodies and Diabodies Using SpyTag/SpyCatcher System for In Vivo Optical Imaging.
    Alam MK; El-Sayed A; Barreto K; Bernhard W; Fonge H; Geyer CR
    Mol Imaging Biol; 2019 Feb; 21(1):54-66. PubMed ID: 29948640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic Modular Antibody Construction by Using the SpyTag/SpyCatcher Protein-Ligase System.
    Alam MK; Gonzalez C; Hill W; El-Sayed A; Fonge H; Barreto K; Geyer CR
    Chembiochem; 2017 Nov; 18(22):2217-2221. PubMed ID: 28891272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of biparatopic antibody through two-step targeting of fragment antibodies on antigen using SpyTag and SpyCatcher.
    Akiba H; Takayanagi K; Kusano-Arai O; Iwanari H; Hamakubo T; Tsumoto K
    Biotechnol Rep (Amst); 2020 Mar; 25():e00418. PubMed ID: 31993343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production in yeast of pseudotype virus-like particles harboring functionally active antibody fragments neutralizing the cytolytic activity of vaginolysin.
    Pleckaityte M; Zvirbliene A; Sezaite I; Gedvilaite A
    Microb Cell Fact; 2011 Dec; 10():109. PubMed ID: 22171920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlling macromolecular topology with genetically encoded SpyTag-SpyCatcher chemistry.
    Zhang WB; Sun F; Tirrell DA; Arnold FH
    J Am Chem Soc; 2013 Sep; 135(37):13988-97. PubMed ID: 23964715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation and identification of single-chain fragment variable against epidermal growth factor receptor 3].
    Liu M; He P; Wen B; Qiu C; Li H; Zhao L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Oct; 35(10):938-943. PubMed ID: 31814571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of recombinant antibodies to rat GABAA receptor subunits by affinity selection on synthetic peptides.
    Koduvayur SP; Gussin HA; Parthasarathy R; Hao Z; Kay BK; Pepperberg DR
    PLoS One; 2014; 9(2):e87964. PubMed ID: 24586298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-translational Assembly of Protein Parts into Complex Devices by Using SpyTag/SpyCatcher Protein Ligase.
    Sutherland AR; Alam MK; Geyer CR
    Chembiochem; 2019 Feb; 20(3):319-328. PubMed ID: 30358052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-Specific Linking of an Oligonucleotide to Mono- and Bivalent Recombinant Antibodies with SpyCatcher-SpyTag System for Immuno-PCR.
    Kushnarova-Vakal A; Äärelä A; Huovinen T; Virta P; Lamminmäki U
    ACS Omega; 2020 Sep; 5(38):24927-24934. PubMed ID: 33015512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of antibody fragment properties for near-infrared fluorescence imaging of HER3-positive cancer xenografts.
    El-Sayed A; Bernhard W; Barreto K; Gonzalez C; Hill W; Pastushok L; Fonge H; Geyer CR
    Theranostics; 2018; 8(17):4856-4869. PubMed ID: 30279742
    [No Abstract]   [Full Text] [Related]  

  • 13. Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.
    Lehmann A; Wixted JH; Shapovalov MV; Roder H; Dunbrack RL; Robinson MK
    MAbs; 2015; 7(6):1058-71. PubMed ID: 26337947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catching a SPY: Using the SpyCatcher-SpyTag and Related Systems for Labeling and Localizing Bacterial Proteins.
    Hatlem D; Trunk T; Linke D; Leo JC
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31052154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid optimization and prototyping for therapeutic antibody-like molecules.
    Xu L; Kohli N; Rennard R; Jiao Y; Razlog M; Zhang K; Baum J; Johnson B; Tang J; Schoeberl B; Fitzgerald J; Nielsen U; Lugovskoy AA
    MAbs; 2013; 5(2):237-54. PubMed ID: 23392215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of divalent anti-keratin 8 single-chain antibodies (sc(Fv)(2)), expression in Pichia pastoris and their reactivity with multicellular tumor spheroids.
    Jafari R; Holm P; Piercecchi M; Sundström BE
    J Immunol Methods; 2011 Feb; 364(1-2):65-76. PubMed ID: 21093447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ScFv Improvement Approaches.
    Bemani P; Mohammadi M; Hakakian A
    Protein Pept Lett; 2018; 25(3):222-229. PubMed ID: 29189116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved scFv Anti-LOX-1 Binding Activity by Fusion with LOX-1-Binding Peptides.
    Hu W; Xie Q; Xiang H
    Biomed Res Int; 2017; 2017():8946935. PubMed ID: 29094051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High avidity scFv multimers; diabodies and triabodies.
    Hudson PJ; Kortt AA
    J Immunol Methods; 1999 Dec; 231(1-2):177-89. PubMed ID: 10648937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion from bacterial versus mammalian cells yields a recombinant scFv with variable folding properties.
    Vendel MC; Favis M; Snyder WB; Huang F; Capili AD; Dong J; Glaser SM; Miller BR; Demarest SJ
    Arch Biochem Biophys; 2012 Oct; 526(2):188-93. PubMed ID: 22230329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.